131 related articles for article (PubMed ID: 33915245)
1. A ten-gene methylation signature as a novel biomarker for improving prediction of prognosis and indicating gene targets in endometrial cancer.
Li X; Yang X; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Genomics; 2021 Jul; 113(4):2032-2044. PubMed ID: 33915245
[TBL] [Abstract][Full Text] [Related]
2. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics data analysis reveals a risk signature and PKD1 induced progression in endometrial cancer patients with postmenopausal status.
Cheng Y; Zhang S; Qiang Y; Dong L; Li Y
Aging (Albany NY); 2022 Jul; 14(13):5554-5570. PubMed ID: 35816294
[TBL] [Abstract][Full Text] [Related]
4. Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer.
Cheng Y; Li X; Dai Y; Dong Y; Yang X; Wang J
J Gynecol Oncol; 2021 May; 32(3):e30. PubMed ID: 33559412
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a prognostic model based on 11 lymph node metastasis-related genes for overall survival in endometrial cancer.
Wu H; Feng H; Miao X; Ma J; Liu C; Zhang L; Yang L
Cancer Med; 2022 Dec; 11(23):4641-4655. PubMed ID: 35778922
[TBL] [Abstract][Full Text] [Related]
6. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.
Liu J; Wu Z; Sun R; Nie S; Meng H; Zhong Y; Nie X; Cheng W
Life Sci; 2020 Oct; 258():118231. PubMed ID: 32791150
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of DNA Methylation and Transcriptome to Identify PD-1-Negative Prognostic Methylated Signature in Endometrial Carcinoma.
Cao L; Ma X; Rong P; Zhang J; Yang M; Wang W
Dis Markers; 2022; 2022():3085289. PubMed ID: 35634444
[TBL] [Abstract][Full Text] [Related]
8. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
[TBL] [Abstract][Full Text] [Related]
9. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
[TBL] [Abstract][Full Text] [Related]
10. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
11. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis.
Huang S; Pang L; Wei C
Front Genet; 2021; 12():678780. PubMed ID: 34616422
[TBL] [Abstract][Full Text] [Related]
13. Identification of HOXB9 to predict prognosis of endometrial cancer based on comprehensive bioinformatics analysis.
Xu Y; Zhang M; Shi Q; Cheng X; Du R; Li C; Zhang Y
Eur J Med Res; 2023 Feb; 28(1):79. PubMed ID: 36803556
[TBL] [Abstract][Full Text] [Related]
14. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
16. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
17. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Jiang P; Sun W; Shen N; Huang X; Fu S
BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients.
Fan Y; Li X; Tian L; Wang J
Front Oncol; 2021; 11():630905. PubMed ID: 33763366
[TBL] [Abstract][Full Text] [Related]
19. Construction of a nine DNA repair-related gene prognostic classifier to predict prognosis in patients with endometrial carcinoma.
Liu J; Jiang P; Chen X; Shen Y; Cui G; Ma Z; Zhao S; Zhang Y
BMC Cancer; 2021 Jan; 21(1):29. PubMed ID: 33407221
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
